Diagnostic challenges of benign/incidental lesions at Liver MRI and CEUS
Webinar 3
![MRI of the Liver](/sites/default/files/styles/hd/public/2023-09/multihance-proposte_settembre2.jpg.webp?itok=SrYJI4eQ)
Focal hepatic lesions are frequently discovered incidentally on cross-sectional imaging and are relatively common in the general population.
Although contrast-enhanced MRI plays a role in characterizing the incidental lesions, we do not forget that CEUS provides a big contribution in this area.
In this Webinar our liver MRI experts will also be joined by a liver CEUS Expert.
The role of ultrasound contrast agent in assessing incidental lesions will be investigated in oncology and non-oncology patients. MRI Experts will address when it is suggested the use of hepatobiliary GBCAs and when extracellular GBCAs could be enough.
A special focus will be made on major diagnostic pitfalls when dealing with benign hepatocellular and non-hepatocellular lesions.
SPEAKERS
Alain Luciani Head of the Medical and University Department for Medical Imaging at University Hospital Henri Mondor AP-HP, France
Christoph F. Dietrich Chief Physician Department of General Internal Medicine (DAIM), Clinic Beau Site, Bern, Switzerland
Luis Marti-Bonmati Director of medical imaging at La Fe University and Polytechnic University Hospital, and chief of radiology at Quirón Hospital, Valencia, Spain
Giovanni Morana Director of Diagnostic Radiology Dept. Ospedale Ca’ Foncello, Treviso, Italy
Günther Schneider Vice Chair Dept. of Diagnostic and Interventional Radiology, Head of MRI Saarland University Medical Center, Homburg, Germany
MODERATOR
Antonella Filippone MD, Head of Medical Affairs and Scientific Information, Bracco Imaging, Milan, Italy
November 9
17:00 - 18:20 CET
The content of the webinar series is intended for European physicians only.
How to attend the webinar
Please register at the following link. You’ll receive the link to join the webinar via email.
Would you like to know more?
See the other two webinars!
Webinar 1
MRI of the Liver:
Choosing the right Contrast Agent
Webinar 2
MRI of Malignant Liver Lesions:
Which MR contrast agent? Which diagnostic criteria?